Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,506
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma

Guiying Suna College of Public Health, Zhengzhou University, Zhengzhou, China;b State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-6717-7228View further author information
ORCID Icon,
Hua Yea College of Public Health, Zhengzhou University, Zhengzhou, China;b State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-3657-2417View further author information
ORCID Icon,
Xiao Wangb State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, China;c Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, ChinaView further author information
,
Lin Chengd College of Life Science, Xinyang Normal University, Xinyang, ChinaView further author information
,
Pengfei Rene Department of Molecular Pathology& Henan Key Laboratory of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Jianxiang Shib State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, China;c Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-4346-3895View further author information
ORCID Icon,
Liping Daib State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, China;c Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-5531-1776View further author information
ORCID Icon,
Peng Wanga College of Public Health, Zhengzhou University, Zhengzhou, China;b State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4666-9706View further author information
ORCID Icon &
Jianying Zhanga College of Public Health, Zhengzhou University, Zhengzhou, China;b State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, China;c Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2938-9526View further author information
ORCID Icon show all
Article: 1814515 | Received 14 Apr 2020, Accepted 20 Aug 2020, Published online: 09 Sep 2020

References

  • Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer. 2019;144(8):1941–10. doi:10.1002/ijc.31937.
  • Zheng RS, Sun KX, Zhang SW. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol. 2019;41:19–28.
  • Cao XQ, Sun XB. Incidence and trend of esophageal cancer[J]. Chin J Clin Oncol. 2016;43(21):932–936. doi:10.3969/j..1000-8179.2016.21.984.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442.
  • Zhang L, Li W, Lyu X, Song Y, Mao Y, Wang S, Huang J. Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma[J]. Chin J Cancer Res. 2017;29(2):149–155. doi:10.21147/j..1000-9604.2017.02.08.
  • Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, Oyama T, Toh Y, Udagawa H, Uno T, et al. Comprehensive registry of esophageal cancer in Japan, 2012[J]. Esophagus. 2019;16(3):221–245. doi:10.1007/s10388-019-00674-z.
  • Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, Dai J, Hu Z, Zhou X, Chen L, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma[J]. Clin Chem. 2010;56(12):1871–1879. doi:10.1373/clinchem.2010.147553.
  • Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata H, Kawaguchi T, et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma[J]. Br J Cancer. 2013;108(9):1822–1829. doi:10.1038/bjc.2013.148.
  • Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system[J]. Immunol Rev. 2008;222(1):328–340. doi:10.1111/j.1600-065X.2008.00611.x.
  • Liu W, Peng B, Lu Y, Xu W, Qian W, Zhang J-Y. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis[J]. Autoimmun Rev. 2011;10:331–335.
  • Zheng SX, Xiang BD, Long JM, Qu C, Mo ZJ, Li K, Zhuang Y, Lv ZL, Zhou SF. Diagnostic value of serum SMP30 and Anti-SMP30 antibody in hepatocellular carcinoma[J]. Lab Med. 2018;1–8. doi:10.1093/labmed/lmy004.
  • Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors[J]. Expert Rev Mol Diagn. 2010;10:321–328. doi:10.1586/erm.10.12.
  • Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Autoantibody biomarkers for the detection of serous ovarian cancer[J]. Gynecol Oncol. 2017;146(1):129–136. doi:10.1016/j.ygyno.2017.04.005.
  • Dai L, Li J, Tsay JJ, Yie T-A, Munger JS, Pass H, Rom WN, Tan EM, Zhang J-Y. Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer[J]. Oncoimmunol. 2017;6:e1310359. doi:10.1080/2162402x.2017.1310359.
  • Pedersen JW, Gentry-Maharaj A, Nostdal A, Fourkala E-O, Dawnay A, Burnell M, Zaikin A, Burchell J, Papadimitriou JT, Clausen H, et al. Cancer-associated autoantibodies to MUC1 and MUC4–a blinded case-control study of colorectal cancer in UK collaborative trial of ovarian cancer screening[J]. Int J Cancer. 2014;134:2180–2188. doi:10.1002/ijc.28538.
  • Loke SY, Lee ASG. The future of blood-based biomarkers for the early detection of breast cancer[J]. Eur J Cancer. 2018;92:54–68. doi:10.1016/j.ejca.2017.12.025.
  • Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies[J]. Oncol Rep. 2006;16:1105–1110.
  • Yang L, Wang J, Li J, Zhang H, Guo S, Yan M, Zhu Z, Lan B, Ding Y, Xu M, et al. Identification of serum biomarkers for gastric cancer diagnosis using a human proteome microarray[J]. Mol Cell Proteomics. 2016;15(2):614–623. doi:10.1074/mcp.M115.051250.
  • Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis[J]. J Clin Invest. 2001;108(10):1411–1415. doi:10.1172/JCI14451.
  • Schwitalle Y, Kloor M, Eiermann S, Linnebacher M, Kienle P, Knaebel HP, Tariverdian M, Benner A, von Knebel Doeberitz M. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers[J]. Gastroenterology. 2008;134(4):988–997. doi:10.1053/j.gastro.2008.01.015.
  • Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. Patterns of somatic mutation in human cancer genomes[J]. Nature. 2007;446(7132):153–158. doi:10.1038/nature05610.
  • Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes[J]. Science. 2013;339(6127):1546–1558. doi:10.1126/science.1235122.
  • Wang S, Qin J, Ye H, Wang K, Shi J, Ma Y, Duan Y, Song C, Wang X, Dai L, et al. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer[J]. Oncoimmunol. 2018;7:e1452582. doi:10.1080/2162402x.2018.1452582.
  • Sobin LH, Gospodarowicz MK, Christian W. TNM classification of malignant tumors. 7th. Oxford, USA: Wiley-Blackwell; 2009.
  • Xu YW, Peng YH, Chen B, Wu Z-Y, Wu J-Y, Shen J-H, Zheng C-P, Wang S-H, Guo H-P, Li E-M, et al. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma[J]. Am J Gastroenterol. 2014;109:36–45. doi:10.1038/ajg.2013.384.
  • Zhang HF, Qin JJ, Ren PF, Shi J-X, Xia J-F, Ye H, Wang P, Song C-H, Wang K-J, Zhang J-Y, et al. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer[J]. Cancer Immunol Immunother. 2016;65:1233–1242. doi:10.1007/s00262-016-1886-6.
  • Le XXN, Chunyang S, Guoli Y. Application of SEREX method in the identification of tumor-associated antigens[J]. Science and Technology of West China, 2009, 8: 56–57
  • Gao Hongjun Zhao Xiaohang. SERPA strategy and its application in tumour-associated antigens[J]. Medical Recapitulate, 2010, 16: 2853–2854
  • Kimple AJ, Bosch DE, Giguere PM, Siderovski DP. Regulators of G-protein signaling and their Galpha substrates: promises and challenges in their use as drug discovery targets[J]. Pharmacol Rev. 2011;63:728–749. doi:10.1124/pr.110.003038.
  • Xiao R, Sun Y, Ding JH, Lin S, Rose DW, Rosenfeld MG, Fu X-D, Li X. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis[J]. Mol Cell Biol. 2007;27:5393–5402. doi:10.1128/mcb.00288-07.
  • Parish AJ, Nguyen V, Goodman AM, Murugesan K, Frampton GM, Kurzrock R. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers[J]. 2018, 124: 4080–4089.doi:10.1002/cncr.31724
  • Terada T. Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions[J]. Pathol Oncol Res. 2012;18(4):1091–1093. doi:10.1007/s12253-011-9374-y.
  • Gong L, Govan JM, Evans EB, Dai H, Wang E, Lee S-W, Lin H-K, Lazar AJ, Mills GB, Lin S-Y, et al. Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure[J]. Cell Cycle. 2015;14(14):2323–2332. doi:10.1080/15384101.2015.1044174.
  • Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. Essential role for nuclear PTEN in maintaining chromosomal integrity[J]. Cell. 2007;128(1):157–170. doi:10.1016/j.cell.2006.11.042.
  • Wu M, Mao C, Chen Q, Cu X-W, Zhang W-S. Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls[J]. Mol Biol Rep. 2010;37:339–343. doi:10.1007/s11033-009-9744-7.
  • Kollias HD, McDermott JC. Transforming growth factor-beta and myostatin signaling in skeletal muscle[J]. J Appl Physiol. 2008;104(1985):579–587. doi:10.1152/japplphysiol.01091.2007.
  • Chen D, Ma T, Liu XW, Liu Z. CASP-8-652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis[J]. Exp Ther Med. 2012;4:762–770. doi:10.3892/etm.2012.661.
  • Horvilleur E, Sbarrato T, Hill K, Spriggs RV, Screen M, Goodrem PJ, Sawicka K, Chaplin LC, Touriol C, Packham G, et al. A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma[J]. Leukemia. 2014;28(5):1092–1102. doi:10.1038/leu.2013.295.
  • Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1[J]. Science. 1997;276:404–407. doi:10.1126/science.276.5311.404.
  • Dai L, Lei N, Liu M, Zhang J-Y. Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)[J]. Exp Hematol Oncol. 2013:2. doi:10.1186/2162-3619-2-15.
  • Dai L, Tsay JC, Li J, Yie T-A, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang J-Y, et al. Autoantibodies against tumor-associated antigens in the early detection of lung cancer[J]. Lung Cancer. 2016;99:172–179. doi:10.1016/j.lungcan.2016.07.018.
  • Zhou SL, Yue WB, Fan ZM, Du F, Liu BC, Li B, Han XN, Ku JW, Zhao XK, Zhang P, et al. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma[J]. Dis Esophagus. 2014;27:790–797. doi:10.1111/dote.12145.
  • Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Calster BV, Collins WP, Vergote I, Huffel SV, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International ovarian tumor analysis group[J]. J Clin Oncol. 2005;23:8794–8801. doi:10.1200/jco.2005.01.7632.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.